Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
Guoqing Ouyang, Bin Yi, Guangdong Pan, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages
Ning Deng, Jie Jin, Yuanyuan Fang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 7
Revealing the Role of High-Density Lipoprotein in Colorectal Cancer
Aleksandra Zeljković, Jelena Vekić, Marija Mihajlović, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3352-3352
Open Access | Times Cited: 32
Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis
Peng Liu, Jinhong Wei, Feiyu Mao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Changing Metabolic Patterns along the Colorectal Adenoma–Carcinoma Sequence
Julia Tevini, Sebastian K. Eder, Ursula Huber-Schönauer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 721-721
Open Access | Times Cited: 19
LCAT Deficiency Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance by Promoting Triglyceride Catabolism and Fatty Acid Oxidation
Min Xu, Peiyi Xie, Shaoqing Liu, et al.
Cancer Letters (2025), pp. 217469-217469
Closed Access
The interaction effect between key autophagy-related biomarkers and HBV/HCV infections on the survival prognosis of hepatocellular carcinoma
Ruiping Wang, Hui Guo, Xiaoni Kou, et al.
Hepatoma Research (2025)
Open Access
Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
Yuan Yang, Guozhi Wu, Qiang Li, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 24
Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
Yongyu Yang, Lei Gao, Junzhang Chen, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9211-9231
Open Access | Times Cited: 17
Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer
Yuyao Wang, Zhan Yang, Ziqun Li, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma
Deyu Zhang, Jiahong Liu, Tian Xie, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 15, pp. 2812-2827
Open Access | Times Cited: 24
Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis
Wanli Yang, Wei Zhou, Xinhui Zhao, et al.
Hereditas (2021) Vol. 158, Iss. 1
Open Access | Times Cited: 23
Anti‑malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer
Liyuan Hao, Shenghao Li, Qing Peng, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 22
A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
Lisa Su, Genhao Zhang, Xiangdong Kong
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer
Federica Polverino, Anna Mastrangelo, Giulia Guarguaglini
Cells (2024) Vol. 13, Iss. 16, pp. 1397-1397
Open Access | Times Cited: 3
Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma
Jiajing Zhao, Zeminshan Luo, Ruizhi Fu, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma
Zhuoyan Chen, Yuan Zeng, Peipei Ma, et al.
Gene (2024) Vol. 933, pp. 148958-148958
Closed Access | Times Cited: 2
Sec62 promotes early recurrence of hepatocellular carcinoma through activating integrinα/CAV1 signalling
Juan Du, Zhihao Zhao, Hetong Zhao, et al.
Oncogenesis (2019) Vol. 8, Iss. 12
Open Access | Times Cited: 18
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes
Chen Xiong, Guifu Wang, Dousheng Bai
Bioengineered (2020) Vol. 11, Iss. 1, pp. 1034-1046
Open Access | Times Cited: 18
Identification of Diagnostic Biomarkers and Subtypes of Liver Hepatocellular Carcinoma by Multi-Omics Data Analysis
Xiao Ouyang, Qingju Fan, Guang Ling, et al.
Genes (2020) Vol. 11, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 17
Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis
Xiaoyan Li, Jinping Wang, Zongliang Guo, et al.
Aging (2023) Vol. 15, Iss. 24, pp. 15084-15113
Open Access | Times Cited: 6
The molecular structure and role of LECT2 or CHM‐II in arthritis, cancer, and other diseases
Sipin Zhu, Samuel Bennett, Yihe Li, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 480-488
Closed Access | Times Cited: 13
Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
Lei Wang, Manman Qiu, Lili Wu, et al.
Infectious Agents and Cancer (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 9
CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma
Xiuzhi Zhang, Xiaoli Liu, Keke Zhu, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Detection of key mRNAs in liver tissue of hepatocellular carcinoma patients based on machine learning and bioinformatics analysis
Maryam Gholizadeh, Seyed Reza Mazlooman, Morteza Hadizadeh, et al.
MethodsX (2023) Vol. 10, pp. 102021-102021
Open Access | Times Cited: 5
Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis
Junwei Liu, Fang Han, Jianyi Ding, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top